| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9b3e6d8f05d9475eab2cebb5c85f9f80 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2200-328
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2200-332
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2002-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-10 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L33-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-20 |
| filingDate |
2020-06-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2d39bd8561b1c55319e3f509826f7876
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7163d4bd53e4434808f7671fa28c7f23
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7b1ac170e051d2a94ca8aaa9f9be8535 |
| publicationDate |
2020-12-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2020251245-A1 |
| titleOfInvention |
Pharmaceutical composition, for treating metabolic diseases, comprising milk-derived exosomes as active ingredient |
| abstract |
The present invention relates to a pharmaceutical composition, for treating metabolic diseases, comprising milk-derived exosomes as an active ingredient. Particularly, the milk-derived exosomes of the present invention comprise mi-155 and mi-375 known to have antidiabetic activity, promote mRNA expression of IRS-1 and GLUT-4 proteins which are factors promoting signal transmission of insulin, and inhibit mRNA expression of C/ EBPβ and PDK4 proteins which are factors inhibiting signal transmission of insulin, and thus can be utilized for treating metabolic diseases. |
| priorityDate |
2019-06-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |